Mingxing Xue
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Deficiency of UCHL1 results in insufficient decidualization accompanied by impaired dNK modulation and eventually miscarriage.
Journal: Journal of translational medicine
Published: January 25, 2024
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing.
Journal: Nature communications
Published: January 06, 2023
An engineered xCas12i with high activity, high specificity, and broad PAM range.
Journal: Protein & cell
Published: October 19, 2022
Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editor.
Journal: Protein & cell
Published: June 26, 2022
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.
Journal: Nature biotechnology
Published: December 17, 2021
Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver.
Journal: Protein & cell
Published: March 19, 2020
The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.
Journal: Theranostics
Published: November 14, 2019
Inflammation-induced inhibition of chaperone-mediated autophagy maintains the immunosuppressive function of murine mesenchymal stromal cells.
Journal: Cellular & molecular immunology
Published: June 05, 2019
The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells.
Journal: Cell death & disease
Published: October 22, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026